Cyprotex
Alexander Argyle is currently employed as a Scientist II at Cyprotex since February 2019. Prior to working at Cyprotex, Alexander was a Graduate Laboratory Technician at Supreme Imports from June 2018 to December 2018. Alexander obtained a MBIOL in Biological Sciences (Biochemistry) with a specialization in Biochemistry from the University of Liverpool in 2018.
This person is not in any offices
Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology